Solvay Pharma Sustainability Profile
Solvay Pharma, a prominent division of Solvay Group, is headquartered in France and operates extensively across Europe, North America, and Asia. Established in 1995, the company has made significant strides in the pharmaceutical industry, focusing on innovative treatments in areas such as central nervous system disorders, women's health, and rare diseases. Renowned for its commitment to research and development, Solvay Pharma offers a range of unique products that address unmet medical needs, setting it apart in a competitive market. With a strong emphasis on sustainability and patient-centric solutions, the company has achieved notable recognition for its contributions to healthcare. As a key player in the pharmaceutical landscape, Solvay Pharma continues to advance its mission of improving patient outcomes through cutting-edge therapies.
DitchCarbon Score
How does Solvay Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Solvay Pharma's score of 26 is lower than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Solvay Pharma's reported carbon emissions
Solvay Pharma, headquartered in France, currently does not report any specific carbon emissions data, as there are no available figures for emissions in kg CO2e. Additionally, the company has not established any documented reduction targets or climate pledges. This lack of data suggests that Solvay Pharma may be in the early stages of developing its climate commitments or may not have publicly disclosed its emissions and sustainability initiatives. In the context of the pharmaceutical industry, many companies are increasingly focusing on reducing their carbon footprints and setting science-based targets to align with global climate goals. However, without specific emissions data or commitments from Solvay Pharma, it is challenging to assess their current position or future plans regarding carbon emissions and climate action.
How Carbon Intensive is Solvay Pharma's Industry?
How Carbon Intensive is Solvay Pharma's Location?
Solvay Pharma's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Solvay Pharma has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
